Infection broncho-pulmonaire à Mycobacterium avium complex

Tsukamura, 1991, Diagnosis of disease caused by Mycobacterium avium complex, Chest, 99, 667, 10.1378/chest.99.3.667 Griffith, 2007, ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases, Am J Respir Crit Care Med, 175, 367, 10.1164/rccm.200604-571ST Dailloux, 2006, Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients, Eur Respir J, 28, 1211, 10.1183/09031936.00063806 Maugein, 2005, Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease, Eur Respir J, 26, 1092, 10.1183/09031936.05.00148604 Rosenzweig, 1979, Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases, Chest, 75, 115, 10.1378/chest.75.2.115 Contreras, 1988, Pulmonary infection with nontuberculous mycobacteria, Am Rev Respir Dis, 137, 149, 10.1164/ajrccm/137.1.149 Wilde, 2008, L’éventail de lady Windermere, 400 Prince, 1989, Infection with Mycobacterium avium complex in patients without predisposing conditions, N Engl J Med, 321, 863, 10.1056/NEJM198909283211304 Reich, 1992, Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome, Chest, 101, 1605, 10.1378/chest.101.6.1605 Wittram, 2002, Mycobacterium avium complex lung disease in immunocompetent patients: radiography-CT correlation, Br J Radiol, 75, 340, 10.1259/bjr.75.892.750340 Fujita, 1999, Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease, Eur Respir J, 13, 535, 10.1183/09031936.99.13353599 Tanaka, 1999, Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease, Am J Respir Crit Care Med, 160, 866, 10.1164/ajrccm.160.3.9811086 Wallace, 1998, Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis, Am J Respir Crit Care Med, 158, 1235, 10.1164/ajrccm.158.4.9712098 Iseman, 1991, Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex, Am Rev Respir Dis, 144, 914, 10.1164/ajrccm/144.4.914 Ziedalski, 2006, Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection, Chest, 130, 995, 10.1378/chest.130.4.995 Mai, 2007, Pulmonary Mycobacterium avium complex infection associated with the IVS8-T5 allele of the CFTR gene, Int J Tuberc Lung Dis, 11, 808 Thomson, 2007, Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease, Chest, 131, 1166, 10.1378/chest.06-1906 Kim, 2008, Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome, Am J Respir Crit Care Med, 178, 1066, 10.1164/rccm.200805-686OC Wallace, 2002, Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis, J Infect Dis, 186, 266, 10.1086/341207 Waller, 2006, The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease, Chest, 130, 1234, 10.1378/chest.130.4.1234 Hanak, 2007, Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis, Mayo Clin Proc, 82, 812, 10.4065/82.7.812 Ji, 1994, Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model, Antimicrob Agents Chemother, 38, 2521, 10.1128/AAC.38.11.2521 Lounis, 1995, Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model, Antimicrob Agents Chemother, 39, 608, 10.1128/AAC.39.3.608 Dautzenberg, 1991, Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial, Am Rev Respir Dis, 144, 564, 10.1164/ajrccm/144.3_Pt_1.564 Dautzenberg, 1993, Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome, Arch Intern Med, 153, 368, 10.1001/archinte.1993.00410030074010 Pierce, 1996, A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome, N Engl J Med, 335, 384, 10.1056/NEJM199608083350603 May, 1997, Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida, Clin Infect Dis, 25, 621, 10.1086/513753 Gordin, 1999, A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex, Clin Infect Dis, 28, 1080, 10.1086/514748 Benson, 2003, A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome, Clin Infect Dis, 37, 1234, 10.1086/378807 Wallace, 1994, Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease, Am J Respir Crit Care Med, 149, 1335, 10.1164/ajrccm.149.5.8173775 Dautzenberg, 1995, Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France, Chest, 107, 1035, 10.1378/chest.107.4.1035 Wallace, 1996, Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients, Am J Respir Crit Care Med, 153, 1766, 10.1164/ajrccm.153.6.8665032 Kobashi, 2007, A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease, Respir Med, 101, 130, 10.1016/j.rmed.2006.04.002 Fujikane, 2005, Efficacy and outcomes of clarithromycin treatment for pulmonary MAC disease, Int J Tuberc Lung Dis, 9, 1281 Lam, 2006, Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease, Am J Respir Crit Care Med, 173, 1283, 10.1164/rccm.200509-1531OC Griffith, 2001, Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease, Clin Infect Dis, 32, 1547, 10.1086/320512 Nelson, 1998, Results of operation in Mycobacterium avium-intracellulare lung disease, Ann Thorac Surg, 66, 325, 10.1016/S0003-4975(98)00401-9 Griffith, 2006, Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease, Am J Respir Crit Care Med, 174, 928, 10.1164/rccm.200603-450OC